期刊文献+

hsBLyS分泌型表达载体构建及CHO表达 被引量:1

Secreting Plasmid Construction and CHO Expression of the Recombinant Human Soluble B Lymphocyte Stimulator
在线阅读 下载PDF
导出
摘要 本实验引物延伸合成人红细胞生成素信号肽序列 ;信号肽序列和人可溶性B淋巴细胞刺激因子 (hu mansolubleBLymphocyteStimulator,hsBLyS)基因重叠延伸拼接成融合基因 ;融合基因插入pcDNA3、pcDNA3 1、pEFneo质粒 ;信号肽引物设计时 ,突变同义密码 ,最终重组质粒成为分泌表达质粒 ;磷酸钙共沉淀将表达质粒和标志质粒pSV dhfr,共转染CHO—dhfr- 细胞 ;选择培养液筛选 ,氨甲喋呤扩增表达 ,获稳定表达rhsBLyS细胞株 ;ELISA检测浓缩表达上清 ,结果表明 :rhsBLyS表达量由 0 13 μg/mL上升至 0 5 5 μg/mL . The B Lymphocyte Stimulator(BLyS), a novel immune regulator, is the most recent addition to the tumor necrosis factor family(TNF) ligands. BlyS induces B cell proliferation, differentiation and immunoglobulin secretion, and involves in immune response of T cell. It also strongly suppresses the growth of tumor cell lines. Fourthermore, BLyS is associated with the development of some autoimmune disease. Here, EPO signal peptide sequence and hsBLyS gene were linked by SOE method. The fusion product was cloned into eukaryotic plasmids:pcDNA3?pcDNA3.1?pEFneo, respectively. Meanwhile, the EPO signal peptide sequence was mutated so as to form a restriction enzyme cut site:BlnⅠ. Thus the recombinant plasmid can be used as secreting plasmid expressing other gene. The recombinant expression plasmid and marker plasmid: pSV-dhfr were co-transfected into CHO-dhfr^-cells. After screened and amplified by selection medium and MTX respectively, we constructed a CHO cell line which secreting express rhsBLyS stably. The level of rhsBLyS expression raised form 0.13?μg/mL to 0.55?μg/mL under the pressure of MTX.
出处 《南京师大学报(自然科学版)》 CAS CSCD 2004年第2期81-86,共6页 Journal of Nanjing Normal University(Natural Science Edition)
基金 国家自然科学基金资助项目 ( 3 0 2 70 193 ) .
关键词 HSBLYS CHO 基因表达 信号肽 分泌型表达载体 免疫调节因子 hsBLyS, Signal peptide, CHO, Secreting expression
  • 相关文献

参考文献12

  • 1Moore P A, Belvedere O, Orr A, et al. BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator[J]. Science,1999,285(5425): 260-263.
  • 2Mukhopadhyay A, Ni J, Zhai Y, et al. Identification and characterization of a novel cytokine,THANK, a TNF homologue that activates apoptosis,nuclear factor-κB,and c-Jun NH2-terminal kinase[J]. J Biol Chem, 1999,274(23):15978-15981.
  • 3Shu H B, Hu W H, Johnson H, et al. TALJ-l is a novel member of the TNF family that is down-regulated by mitogens[J] . J Leukoc Biol, 1999,65(5) :680-683.
  • 4Mackay F, Woodcock S A, Lawton P, et al. TACI and BCMA are receptors for a TNF homologue implicated in B cell autoimmune disease[J]. Nature, 2000,404: 995-999.
  • 5Tribouley C, Wallroth M, Chan V, et al. Characterization of a new member of the TNF family expressed on antigen preseming cells[J]. Biol Chem, 1999,380: 1443-1447.
  • 6Wang H, Marsters S A, Baker T, et al. TACI ligand interactions are required for T cell activation and collagen induced arthritis in mice[J]. Nat Immunol,2001,2:632-637.
  • 7Khare S D, Sarosi I, Xia X Z, et al. Severe B cell hyperplasia an autoimmune disease in TALL-1 transgenic mice[J]. Proc Natl Aca Sci USA, 2000,97 (7): 3370-3375.
  • 8Horton R M, Hunt H D, Ho S N, et al. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension Gene[ J ]. 1989,77 ( 1 ): 61-68.
  • 9余兴龙,涂长春,李红卫,陈创夫,李作生,马正海,孙明,殷震.猪瘟病毒E2基因真核表达质粒的构建及基因疫苗的研究[J].中国病毒学,2000,15(3):264-271. 被引量:50
  • 10Kaufman R J, Sharp P A, Latt S A, et al. Evolution of chromosomal regions containing transfected and amplified dihydrofolate reductase sequences[J]. Mol Cell Biol, 1983,3(4):699-711.

二级参考文献8

  • 1谢庆阁 翟中和.畜禽重大疫苗免疫防制研究[M].北京:中国农业科技出版社,1997.22-26.
  • 2苏慧慈 刘彦仿.原位PCR[M].北京:科学出版社,1997.39-81.
  • 3余兴龙 涂长春 等.猪IL-2和IL-6 cDNA的克隆及序列测量[J].中国兽医学报,1999,19:39-39.
  • 4余兴龙,中国兽医学报,1999年,19卷,39页
  • 5谢庆阁,畜禽重大疫病免疫防治研究,1997年,22页
  • 6苏慧慈,原位PCR,1997年,39页
  • 7Tang D,Nature,1992年,356卷,152页
  • 8余兴龙,涂长春,李作生,马正海,李红卫,吴健敏,吕宗吉,殷震.以重组mE2蛋白为抗原建立检测猪瘟病毒抗体间接ELISA方法的研究[J].中国预防兽医学报,1999,21(3):220-222. 被引量:46

共引文献49

同被引文献10

  • 1张立,何凤田,高会广,李蓉芬,彭家和,陈麟凤,黄刚,胡大强.人mBAFF在原核系统的可溶性表达及功能鉴定[J].免疫学杂志,2006,22(2):217-220. 被引量:2
  • 2Davidson A.Targeting BAFF in autoimmunity[J].Curr Opin Immu-nol,2010,22(6):732-739.
  • 3Dalakas MC.B cells as therapeutic targets in autoimmune neurologicaldisorders[J].Nat Clin Pract Neurol,2008,4(10):557-567.
  • 4Meinl E,Derfuss T,Krumbholz M,et al.Humoral autoimmunity inmultiple sclerosis[J].J Neurol Sci,2011,306(1-2):180-182.
  • 5Rauch M,Tussiwand R,Bosco N,et al.Crucial role for BAFF-BAFF-R signaling in the survival and maintenance of mature B cells[J/OL].PLoS One,2009,4(5):e5456.
  • 6Sasaki Y,Derudder E,Hobeika E,et al.Canonical NF-kappaB ac-tivity,dispensable for B cell development,replaces BAFF-receptorsignals and promotes B cell proliferation upon activation[J].Immuni-ty,2006,24(6):729-739.
  • 7Lied GA,Berstad A.Functional and clinical aspects of the B-cell-ac-tivating factor(BAFF):a narrative review[J].Scand J Immunol,2011,73(1):1-7.
  • 8Mackay F,Schneider P.Cracking the BAFF code[J].Nat Rev Im-munol,2009,9(7):491-502.
  • 9Liu F,Song Y,Liu D.Hydrodynamics-based transfection in animalsby systemic administration of plasmid DNA[J].Gene Ther,1999,6(7):1258-1266.
  • 10丁涵露,吴雄飞,何娅妮,倪兵.hBAFF-R-Fc融合分子的构建、表达与鉴定[J].免疫学杂志,2008,24(5):495-499. 被引量:1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部